Poly(L‐Glutamic Acid)‐Drug Conjugates for Chemo‐ and Photodynamic Combination Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poly(L‐Glutamic Acid)‐Drug Conjugates for Chemo‐ and Photodynamic Combination Therapy
Authors
Keywords
-
Journal
MACROMOLECULAR BIOSCIENCE
Volume -, Issue -, Pages 2000192
Publisher
Wiley
Online
2020-10-12
DOI
10.1002/mabi.202000192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma
- (2019) Yalin Wang et al. Acta Biomaterialia
- PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly( l ‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer
- (2019) Hanjiao Qin et al. Advanced Science
- Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug
- (2019) Jian Jiang et al. ADVANCED MATERIALS
- Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment
- (2019) Na Shen et al. NANO LETTERS
- Metal Ion/Tannic Acid Assembly as a Versatile Photothermal Platform in Engineering Multimodal Nanotheranostics for Advanced Applications
- (2018) Tao Liu et al. ACS Nano
- Biomimetic O 2 -Evolving metal-organic framework nanoplatform for highly efficient photodynamic therapy against hypoxic tumor
- (2018) Shutao Gao et al. BIOMATERIALS
- Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility
- (2016) Anne Close Future Medicinal Chemistry
- Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance
- (2016) Wantong Song et al. JOURNAL OF CONTROLLED RELEASE
- A cooperative polymeric platform for tumor-targeted drug delivery
- (2016) Wantong Song et al. Chemical Science
- Solid Tumor Therapy Using a Cannon and Pawn Combination Strategy
- (2016) Wantong Song et al. Theranostics
- Cisplatin-loaded polymeric nanoparticles: Characterization and potential exploitation for the treatment of non-small cell lung carcinoma
- (2015) Chunshan Shi et al. Acta Biomaterialia
- Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(l-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy
- (2015) Haiyang Yu et al. JOURNAL OF CONTROLLED RELEASE
- Coadministration of Vascular Disrupting Agents and Nanomedicines to Eradicate Tumors from Peripheral and Central Regions
- (2015) Wantong Song et al. Small
- Classification and Toxicities of Vascular Disrupting Agents
- (2011) Arman Hasani et al. Clinical Lung Cancer
- The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents
- (2010) Dietmar W. Siemann CANCER TREATMENT REVIEWS
- Hypocrellin B doped and pH-responsive silica nanoparticles for photodynamic therapy
- (2010) ZhaoBo Li et al. Science China-Chemistry
- Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo
- (2009) P. G. Tardi et al. MOLECULAR CANCER THERAPEUTICS
- 423 POSTER Phase I dose escalation study of NK012, polymer micelle of irinotecan metabolite SN-38, in patients with advanced cancer
- (2008) D. Toshihiko et al. EJC SUPPLEMENTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now